Article Text
Editors' Choice
Highlights from this issue
Statistics from Altmetric.com
“What's in a name? That which we call a rose
By any other name would smell as sweet”
William Shakespeare, Romeo and Juliet, act 2 scene 1 line 85.
What is in a name? We hesitate to contradict the Bard but we think a name is very important, at least in neurological practice. In our last edition, Tom Hughes1 argued that using the term ‘stroke’ to describe a rapid onset neurological deficit leads to diagnostic error—as the term now implies a vascular aetiology for the deficit, and its use impedes too soon diagnostic consideration of alternatives. He suggested that transient or persistent change in (neurological) function should be the first descriptor, rather than stroke or …
Read the full text or download the PDF:
Other content recommended for you
- Performance validity test failure in clinical populations—a systematic review
- Dissociative (non-epileptic) seizures: tackling common challenges after the diagnosis
- ‘Cryptogenic Drop Attacks’ revisited: evidence of overlap with functional neurological disorder
- Functional (psychogenic non-epileptic/dissociative) seizures: why and how?
- Functional cognitive disorders: clinical presentations and treatment approaches
- Functional movement disorder gender, age and phenotype study: a systematic review and individual patient meta-analysis of 4905 cases
- Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease
- Weakened functional connectivity in patients with psychogenic non-epileptic seizures (PNES) converges on basal ganglia
- Functional neurological disorders in Parkinson disease
- Protocol for validating an algorithm to identify neurocognitive disorders in Canadian Longitudinal Study on Aging participants: an observational study